MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

20 Oct 2022 Evaluate
The Top line for the quarter ended September 2022 of Rs. 0.68 millions up 88.89% from Rs. 0.36 millions.The Company's Net profit for the September 2022 quarter have declined marginally to Rs. 1.35  millions as against Rs. 1.84 millions reported during the corresponding quarter ended.OP of the company witnessed a marginal growth to 2.28 millions from 2.02 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.68 0.36 88.89 2.76 0.59 367.80 3.65 69.91 -94.78
Other Income 4.32 4.27 1.17 8.73 8.05 8.45 19.19 14.66 30.90
PBIDT 2.28 2.02 12.87 5.16 3.03 70.30 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.28 2.02 12.87 5.16 3.03 70.30 10.25 23.12 -55.67
Depreciation 0.23 0.18 27.78 0.46 0.32 43.75 0.92 0.58 58.62
PBT 2.05 1.84 11.41 4.70 2.71 73.43 9.33 22.54 -58.61
TAX 0.70 0.00 0.00 1.40 0.00 0.00 4.57 8.05 -43.23
Deferred Tax -0.30 0.00 0.00 0.40 0.00 0.00 0.22 4.48 -95.09
PAT 1.35 1.84 -26.63 3.30 2.71 21.77 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 335.29 561.11 -40.24 186.96 513.56 -63.60 280.82 33.07 749.15
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..